PTC Therapeutics (PTCT) Misses Q3 EPS by 66c, Revenues Miss; Lowers FY18 Revenue Outlook
Go back to PTC Therapeutics (PTCT) Misses Q3 EPS by 66c, Revenues Miss; Lowers FY18 Revenue Outlook| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 65.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.37 | 52 Week High | $35.40 | |||
| Open | $65.37 | 52 Week Low | $4.03 | |||
| Day High | $65.37 | P/E | 6.95 | |||
| Day Low | $65.37 | EPS | $9.40 | |||
| Volume | 418 | |||||
